Dana-Farber Cancer Institute president and CEO Dr. Laurie H. Glimcher has announced she will step down on October 1 and assume the title of president emerita.

Dr. Benjamin Levine Ebert, chair of the Department of Medical Oncology, will serve as the next president and CEO of Dana-Farber, effective October 1.